IP Library Granted Patent US 11,351,364
Granted Patent B2
US 11,351,364 · App. 16/870,455 · Granted Jun 7, 2022

Apparatus, system, and method for selective stimulation

Inventors: Paul M. Meadows (Glendale, CA); Marcelo G. Lima (San Diego, CA); Stanley R. Craig (Westport, MA)
Assignee: ImThera Medical, Inc.
A61N1/0556A61N1/3605A61N1/3611A61N1/378A61N1/3787A61N1/37217A61N1/37514A61N1/36071A61N1/36135A61N1/3758
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,351,364
App. No.
16/870,455
Granted
Jun 7, 2022
Kind
B2
Abstract

An implantable neurostimulator system is disclosed, the neurostimulator system comprising a hollow cylindrical electronics enclosure having a top, a bottom, and a side; a coil extending from a first part of the electronics enclosure; and at least one electrode operatively connected to the electronics enclosure.

Claims (32)

1. A method of treating sleep apnea using neurostimulation, the method comprising the steps of:

electrically coupling a plurality of contacts of an electrode to a hypoglossal nerve of a patient;

implanting an implantable pulse generator (IPG) into a sub-mandibular space of the patient, the IPG being electronically coupled to the electrode and comprising a radio-frequency (RF) interface configured to receive power from an external power source; and

programming the IPG to deliver at least two electric signals to the plurality of contacts during a therapy session, where one of the at least two electric signals overlaps with another of the at least two electric signals such that current fields generated at the plurality of contacts combine to form an overlapping current field.

2. The method of claim 1 , further comprising applying the power to the IPG from the external power source via the RF interface.

3. The method of claim 1 , further comprising receiving, by the IPG, control signals from an external controller via the RF interface.

4. The method of claim 1 , wherein the external power source is held in position proximate the RF interface using an adhesive.

5. The method of claim 1 , wherein the IPG is powered using RF power provided at a signal frequency between 10 MHz and 15 MHz.

6. The method of claim 1 , wherein the IPG is powered using RF power provided at a signal frequency of approximately 13.56 MHz.

7. The method of claim 1 , wherein the RF interface includes an internal coil and an internal magnet, and the internal magnet is configured to align the internal coil with an external coil of the external power source.

8. A method of treating sleep apnea using neurostimulation, the method comprising the steps of:

electrically coupling a plurality of first contacts of a first electrode to a first hypoglossal nerve of a patient;

electrically coupling a plurality of second contacts of a second electrode to a second hypoglossal nerve of the patient;

implanting an implantable pulse generator (IPG) into a sub-mandibular space of the patient, the IPG being electronically coupled to the first electrode and the second electrode, the IPG including a radio-frequency (RF) interface configured to receive power from an external power source;

programming the IPG to deliver at least two electric signals to at least one of the plurality of first contacts or the plurality of second contacts during a therapy session, where one of the at least two electric signals overlaps with another of the at least two electric signals such that current fields generated at the at least one of the plurality of first contacts or the plurality of second contacts combine to form an overlapping current field; and

applying the power to the IPG from the external power source via the RF interface during the therapy session.

9. The method of claim 8 , further comprising receiving, by the IPG, control signals from an external controller via the RF interface.

10. The method of claim 8 , wherein the external power source is held in position proximate the RF interface using an adhesive.

11. The method of claim 8 , wherein the IPG is powered using RF power provided at a signal frequency between 10 MHz and 15 MHz.

12. The method of claim 8 , wherein the IPG is powered using RF power provided at a signal frequency of approximately 13.56 MHz.

13. The method of claim 8 , wherein the RF interface includes an internal coil and an internal magnet, and the internal magnet is configured to align the internal coil with an external coil of the external power source.

14. The method of claim 8 , wherein the RF interface includes one or more of a transponder, an internal antenna, a modulator, a demodulator, a clock, a rectifier, an inductive coupler, an RF to DC converter, or a flat coil.

15. A system for treating sleep apnea using neurostimulation, the system comprising:

an electrode having a plurality of contacts, the electrode configured to be implanted into a patient, the plurality of contacts configured to be electrically coupled to a Hypoglossal nerve of the patient;

an implantable pulse generator (IPG) configured to be implanted into a sub-mandibular space of the patient, the IPG being electronically coupled to the electrode and comprising a radio-frequency (RF) interface, the IPG being programmed to:

deliver at least two electric signals to the plurality of contacts during a therapy, where one of the at least two electric signals overlaps with another of the at least two electric signals such that current fields generated at the plurality of contacts by the at least two electric signals overlap and combine to form an overlapping current field; and

an external power source configured to apply power to the IPG via the RF interface when the IPG has been implanted into the sub-mandibular space of the patient.

16. The system of claim 15 , further comprising an external controller configured to provide control signals to the IPG via the RF interface when the IPG has been implanted into the sub-mandibular space of the patient.

17. The system of claim 15 , wherein the external power source is configured to apply RF power to the IPG via the RF interface at a signal frequency between 10 MHz and 15 MHz.

18. The system of claim 15 , wherein the external power source is configured to apply RF power to the IPG via the RF interface at a signal frequency of approximately 13.56 MHz.

19. The system of claim 15 , wherein the RF interface is further configured to support bidirectional data and command telemetry.

20. The system of claim 15 , wherein the RF interface includes a transponder having separate channels for power delivery and control signal delivery.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2022
From: MEADOWS, PAUL M.; LIMA, MARCELO G.; CRAIG, STANLEY R.
To: IMTHERA MEDICAL, INC.
Reel/Frame 059624/0648 →
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: ACF FINCO I LP
To: IMTHERA MEDICAL, INC.
Reel/Frame 057535/0850 →
SECURITY INTEREST Recorded Aug 16, 2021
From: IMTHERA MEDICAL, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 057188/0115 →
RELEASE OF SECURITY INTEREST Recorded Aug 16, 2021
From: ARES CAPITAL CORPORATION, AS AGENT FOR THE LENDERS
To: IMTHERA MEDICAL, INC.
Reel/Frame 057188/0573 →
PATENT SECURITY AGREEMENT Recorded Dec 30, 2020
From: IMTHERA MEDICAL, INC.
To: ACF FINCO I LP, AS COLLATERAL AGENT
Reel/Frame 054881/0683 →
PATENT SECURITY AGREEMENT Recorded Jun 17, 2020
From: IMTHERA MEDICAL, INC.
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 052963/0651 →
Continuity (8)
Continuation 15851964 · Dec 22, 2017
Continuation 14811171 · Jul 28, 2015
Continuation 13775349 · Feb 25, 2013
Continuation 12681812
Provisional Application 61136102 · Aug 12, 2008
Provisional Application 61017614 · Dec 29, 2007
Provisional Application 60978519 · Oct 9, 2007
Related Publication 20200338339A1 · Oct 29, 2020